MIRA INFORM REPORT

 

 

Report No. :

342627

Report Date :

29.09.2015

 

IDENTIFICATION DETAILS

 

Name :

OPTIMUS DRUGS PRIVATE LIMITED (w.e.f.10.01.2009)

 

 

Formerly Known As :

SURYA KIRAN LABS PRIVATE LIMITED

 

 

Registered Office :

H.No.4-7-101, Scientist Colony, Nacharam, Hyderabad – 500007, Telangana

Tel. No.:

91-40-27174651

 

 

Country :

India

 

 

Financials (as on) :

31.03.2014

 

 

Date of Incorporation :

02.12.2003

 

 

Com. Reg. No.:

36-042155

 

 

Capital Investment / Paid-up Capital :

Rs. 58.917 Million

 

 

CIN No.:

[Company Identification No.]

U24239TG2003PTC042155

 

 

IEC No.:

0908003404

 

 

TAN No.:

[Tax Deduction & Collection Account No.]

Not Available

 

 

PAN No.:

[Permanent Account No.]

AAHCS8074N

 

 

Legal Form :

Private Limited Liability Company

 

 

Line of Business :

Manufacturer of Bulk Drugs and Intermediates

 

 

No. of Employees :

100 (Approximately)

 

 

RATING & COMMENTS

 

MIRA’s Rating :

Ba (45)

 

RATING

STATUS

PROPOSED CREDIT LINE

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

Satisfactory

 

Maximum Credit Limit :

USD 500000

 

 

Status :

Satisfactory

 

 

Payment Behaviour :

Usually correct

 

 

Litigation :

Clear

 

 

Comments :

Subject was incorporated in the year 2003 and it is a manufacturer of bulk drugs.

 

For the financial year ended 2014, company reported satisfactory operational performance and it has maintained sound profitability margin at 2.48%.

 

Rating also takes into consideration company’s sound financial base marked by adequate networth base and favorable gap between trade payables to its receivables.

 

Trade relations are reported as fair. Payment terms are reported to be usually correct.

 

The company can be considered for business dealings at usual trade terms and condition.  

 

NOTES :

Any query related to this report can be made on e-mail : infodept@mirainform.com while quoting report number, name and date.

 

ECGC Country Risk Classification List – March 31, 2015

 

Country Name

Previous Rating

(31.12.2014)

Current Rating

(31.03.2015)

India

A1

A1

 

Risk Category

ECGC Classification

Insignificant

 

A1

Low

 

A2

Moderate

 

B1

High

 

B2

Very High

 

C1

Restricted

 

C2

Off-credit

 

D

 

 

EXTERNAL AGENCY RATING

 

 

Rating Agency Name

Not Available

Rating

Not Available

Rating Explanation

Not Available

Date

Not Available

 

 

RBI DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available RBI Defaulters’ list.

 

EPF (Employee Provident Fund) DEFAULTERS’ LIST STATUS

 

Subject’s name is not enlisted as a defaulter in the publicly available EPF (Employee Provident Fund) Defaulters’ list as of 31-03-2015.

 

INFORMATION PARTED BY

 

Name :

Mr. Samant Reddy

Designation :

Account Manager

Contact No.:

91-40-40069400

Date :

25.09.2015

 

 

 

LOCATIONS

 

Registered Office/ Factory 1 :

H.No.4-7-101, Scientist Colony, Nacharam, Hyderabad – 500007, Telangana, India

Tel. No.:

91-40-27174651

Fax No.:

Not Available

E-Mail :

info@optimuspharma.com

askrco@yahoo.com

Website :

http://www.optimuspharma.com

Location :

Owned

 

 

Corporate Office / Administrative Office :

1-2-11/1, Above SBI Bank, Street No. 2, Kakatiya Nagar, Habsiguda, Hyderabad - 500007, Telangana, India

Tel. No.:

91-40-40069400

Fax No.:

91-40-40069401

E-Mail.:

info@optimuspharma.net 

Website :

www.optimuspharma.net

Location :

Owned

 

 

Factory 2 :

Survey No. 239 and 240, Dothigudem (V), Pochampally (M), Nalgonda (District) - 508284, Telangana, India

 

 

DIRECTORS

 

As on 30.09.2014

 

Name :

Mr. Srinivas Reddy Desi Reddy

Designation :

Director

Address :

H No. 9-119, Flat No. 6, Himayat Nagar, Nacharam, Hyderabad – 500076, Telangana, India

Date of Birth/Age :

19.01.1973

Date of Appointment :

30.03.2006

PAN No.:

AFLPB9675G

DIN No.:

01819852

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Company/ LLP Status

Defaulting status

1

U24239AP2004PTC044232

OPTIMUS PHARMA PRIVATE LIMITED

Managing director

21/09/2004

21/09/2004

Active

NO

2

U24239TG2003PTC042155

OPTIMUS DRUGS PRIVATE LIMITED

Director

30/03/2006

30/03/2006

Active

NO

3

U27100WB2008PTC123888

TWINE STEEL PRIVATE LIMITED

Director

17/10/2011

17/10/2011

Strike off

NO

4

U24233TG2012PTC079927

OPTRIX LABORATORIES PRIVATE LIMITED

Director

13/06/2013

13/06/2013

Active

NO

5

U24233TG2014PTC094608

OPTIMUS GENERICDRUGS PRIVATE LIMITED

Director

24/06/2014

24/06/2014

Active

NO

 

 

Name :

Mr. Venkata Srinivasarao Velivela

Designation :

Director

Address :

H No.580, C2 Road, No.46, Vivekananda Nagar, Kukatpally, Hyderabad – 500072, Telangana, India

Date of Birth/Age :

07.05.1970

Date of Appointment :

01.01.2010

DIN No.:

01448900

Other Directorship :

 

S.No.

CIN/LLPIN

Name of the Company/ LLP

Current designation of the Director/ Designated Partner

Date of appointment at current designation

Original date of appointment

Date of cessation

Company/ LLP Status

Defaulting status

1

U24230TG2005PTC045300

USHA VITAL CARE PRIVATE LIMITED

Director

30/05/2005

30/05/2005

27/01/2011

Active

NO

2

U24239TG2003PTC042155

OPTIMUS DRUGS PRIVATE LIMITED

Director

01/01/2010

01/01/2010

-

Active

NO

3

U24233TG2012PTC079927

OPTRIX LABORATORIES PRIVATE LIMITED

Director

13/06/2013

13/06/2013

-

Active

NO

 

 

KEY EXECUTIVES

 

Name :

Mr. Samant Reddy

Designation :

Account Manager

 

 

MAJOR SHAREHOLDERS / SHAREHOLDING PATTERN

 

As on 30.09.2014

 

Names of Shareholders

 

No. of Shares

Srinivas Reddy Desi Reddy

 

2991787

Venkata Srinivasarao Velivela

 

454825

D. Shiva Reddy

 

1037955

D. Prameela

 

376416

D. Triveni

 

31667

K. Kasthuri

 

74399

Hanimi Reddy

 

16667

Adilakshmi

 

16667

G. Appi Reddy

 

25000

Obul Reddy

 

8333

P. Prashath Reddy

 

233

Shiresha

 

16667

M. Srinivasa Rao

 

12750

Twinw Steel Private Limited

 

211667

N. Yellamanda Reddy

 

16667

Total

 

5891700

 

Equity Share Break up (Percentage of Total Equity)

 

As on 30.09.2014

 

Category

Percentage

Other top 50 shareholders

100.00

 

 

Total

100.00

 

 

 

BUSINESS DETAILS

 

Line of Business :

Manufacturer of Bulk Drugs and Intermediates

 

 

Products :

Item Code No.

Product Description

98041000

Bulk Drugs and Intermediates

 

 

Brand Names :

Not Available

 

 

Agencies Held :

Not Available

 

 

Exports :

Not Available

 

 

Imports :

 

Products :

Raw Material

Countries :

China

 

 

Terms :

 

Selling :

Cash and Credit (30/60/90, Days)

 

 

Purchasing :

Cash and Credit (30/60/90, Days)

 

PRODUCTION STATUS NOT AVAILABLE

 

GENERAL INFORMATION

 

Suppliers :

Reference :

Not Divulged

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

Customers :

End Users and OEMs

  • Novartis India Limited
  • Lupin Limited
  • Glenmark Pharmaceuticals Limited
  • Cipla
  • Abbott

Reference :

Mylan Pharmaceuticals Private Limited

Name of the Person :

Not Divulged

Contact No.:

Not Divulged

Since How Long Known :

Not Divulged

Maximum Limit Dealt :

Not Divulged

Experience :

Not Divulged

Remark:

Not Divulged

 

 

No. of Employees :

100 (Approximately) 

 

 

Bankers :
  • ICICI Bank Limited, Landmark Race Cource Circle, Alkapuri, Vadodara- 390015, Gujarat, India

 

·         Axis Bank Limited, 1st Floor, G. Pullareddy Building, 6-3-879/B, Green Lands, Begumpet, Hyderabad - 500016, Telangana, India

 

  • Standard Chartered Bank, Door No.8-2-293/82/A/646A, Ground Floor, Adityaram Square Road No. 36, Jubilee Hills, Hyderabad - 500003, Telangana, India

 

Bank Name

Bank of India

Branch

Saifabad, Hyderabad, Telangana, India

Person Name (With Designation)

Not Divulged

Contact Number

91-40-23244464 (Not Responding)

Name of Account Holder

Not Divulged

Account Number

Not Divulged

Account Since (Date/Year of Account Opening)

Not Divulged

Average Balance Maintained (If Possible)

Not Divulged

Credit Facilities Enjoyed (If any)

Cash Credit Rs. 68.000 Million

Account Operation

Not Divulged

Remarks (If any)

Not Divulged

 

 

Facilities :

(Rs. In Million)

SECURED LOAN

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Term loan from banks

73.972

24.302

 

 

 

SHORT TERM BORROWING

 

 

Loans repayable on demand

56.358

29.753

Total

130.330

54.055

 

Auditors :

 

Name :

S. Kasthuri Rengan and Company

Chartered Accountants

Address :

Flat No. 909 A, 9th Floor, Raghava Ratna Towers, Chirag Ali Lane, ABIDS, Hyderabad – 500001, Telangana, India

PAN N Income-tax PAN of auditor or auditor's firm :

ABVFS0052L

 

 

Memberships :

--

 

 

Collaborators :

--

 

 

Associates :

Name:

Optimum Pharma Private Limited

Address:

H.No.4-7-101, Scientist Colony, Nacharam, Hyderabad – 500007, Telangana, India

Line of Business:

Producer of Pharmaceutical Substances

 

 

CAPITAL STRUCTURE

 

As on 30.09.2014

 

Authorised Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

7200000

Equity Shares

Rs.10/- each

Rs. 72.000 Million

 

 

 

 

 

Issued, Subscribed & Paid-up Capital :

No. of Shares

Type

Value

Amount

 

 

 

 

5891700

Equity Shares

Rs.10/- each

Rs. 58.917 Million

 

 

 

 

 

 

 

FINANCIAL DATA

[all figures are in Rupees Million]

 

 

ABRIDGED BALANCE SHEET

 

 

SOURCES OF FUNDS

 

31.03.2014

31.03.2013

31.03.2012

I.              EQUITY AND LIABILITIES

 

 

 

(1)Shareholders' Funds

 

 

 

(a) Share Capital

58.917

28.689

28.689

(b) Reserves & Surplus

118.173

47.129

26.123

(c) Money received against share warrants

0.000

0.000

0.000

 

 

 

 

(2) Share Application money pending allotment

0.000

41.825

25.770

Total Shareholders’ Funds (1) + (2)

177.090

117.643

80.582

 

 

 

 

(3) Non-Current Liabilities

 

 

 

(a) long-term borrowings

125.173

69.899

64.326

(b) Deferred tax liabilities (Net)

9.659

5.942

4.000

(c) Other long term liabilities

25.119

8.489

0.000

(d) long-term provisions

0.000

0.000

0.000

Total Non-current Liabilities (3)

159.951

84.330

68.326

 

 

 

 

(4) Current Liabilities

 

 

 

(a) Short term borrowings

56.358

29.753

0.000

(b) Trade payables

230.211

222.963

194.033

(c) Other current liabilities

14.825

5.236

6.512

(d) Short-term provisions

15.388

11.192

0.000

Total Current Liabilities (4)

316.782

269.144

200.545

 

 

 

 

TOTAL

653.823

471.117

349.453

 

 

 

 

II.            ASSETS

 

 

 

(1) Non-current assets

 

 

 

(a) Fixed Assets

 

 

 

(i) Tangible assets

228.341

125.500

83.974

(ii) Intangible Assets

0.552

0.859

1.166

(iii) Capital work-in-progress

0.000

0.000

0.000

(iv) Intangible assets under development

0.000

0.000

0.000

(b) Non-current Investments

0.000

0.000

0.000

(c) Deferred tax assets (net)

0.000

0.000

0.000

(d)  Long-term Loan and Advances

0.000

0.000

0.000

(e) Other Non-current assets

0.000

0.000

0.000

Total Non-Current Assets

228.893

126.359

85.140

 

 

 

 

(2) Current assets

 

 

 

(a) Current investments

0.000

0.000

0.000

(b) Inventories

54.132

58.160

48.146

(c) Trade receivables

280.615

219.347

172.617

(d) Cash and cash equivalents

7.011

6.691

6.490

(e) Short-term loans and advances

83.172

60.560

37.060

(f) Other current assets

0.000

0.000

0.000

Total Current Assets

424.930

344.758

264.313

 

 

 

 

TOTAL

653.823

471.117

349.453

 

 

PROFIT & LOSS ACCOUNT

 

 

PARTICULARS

31.03.2014

31.03.2013

31.03.2012

 

SALES

 

 

 

 

Income

1201.737

768.761

605.940

 

Other Income

 N.A

0.262

0.117

 

TOTAL

N.A

769.023

606.057

 

 

 

 

 

EXPENSES

 

 

 

 

Materials and Manufacturing Expenses

 

666.815

576.966

 

Changes in inventories of finished goods, work-in-progress and Stock-in-Trade

 

8.282

(27.510)

 

Employees benefits expense

 

24.901

16.306

 

Other expenses

22.654

12.990

 

TOTAL

N.A

722.652

578.752

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE INTEREST, TAX, DEPRECIATION AND AMORTISATION

N.A

46.371

27.305

 

 

 

 

 

FINANCIAL EXPENSES

 N.A

5.607

2.954

 

 

 

 

 

 

PROFIT / (LOSS) BEFORE TAX, DEPRECIATION AND AMORTISATION 

30.210

40.764

24.351

 

 

 

 

 

DEPRECIATION/ AMORTISATION

14.756

9.317

6.892

 

 

 

 

 

 

PROFIT/ (LOSS)  BEFORE TAX

44.966

31.447

17.459

 

 

 

 

 

 

TAX

15.063

10.442

5.893

 

 

 

 

 

 

PROFIT/ (LOSS)  AFTER TAX 

29.903

21.005

11.566

 

 

 

 

 

 

Earnings / (Loss) Per Share (Rs.)

5.07

4.07

1.96

 

 

Particulars

 

 

 

31.03.2015

Sales Turnover (Approximately)

 

 

1500.000

 

The above information has been parted by Mr. Samant Reddy (Accounts Manager)

 

CURRENT MATURITIES OF LONG TERM DEBT DETAILS

 

Particulars

 

31.03.2014

31.03.2013

31.03.2012

Current Maturities of Long term debt

N.A

N.A

N.A

Cash generated from operations

N.A

N.A

N.A

Net cash flows from (used in) operations

44.966

31.446

N.A

 

 

KEY RATIOS

 

 

PARTICULARS

 

 

31.03.2014

31.03.2013

31.03.2012

Net Profit Margin

(PAT / Sales)

(%)

2.49

3.12

1.91

 

 

 

 

 

Operating Profit Margin

(PBIDT/Sales)

(%)

N.A

6.03

4.51

 

 

 

 

 

Return on Total Assets

(PBT/Total Assets}

(%)

6.88

6.67

5.00

 

 

 

 

 

Return on Investment (ROI)

(PBT/Networth)

 

0.25

0.27

0.22

 

 

 

 

 

Debt Equity Ratio

(Total Debt /Networth)

 

1.03

0.85

0.80

 

 

 

 

 

Current Ratio

(Current Asset/Current Liability)

 

1.34

1.28

1.32

 

 

FINANCIAL ANALYSIS

[all figures are in Rupees Million]

 

 

DEBT EQUITY RATIO

 

Particular

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Share Capital

28.689

28.689

58.917

Reserves & Surplus

26.123

47.129

118.173

Money received against share warrants

0.000

0.000

0.000

 Share Application money pending allotment

25.770

41.825

0.000

Net worth

80.582

117.643

177.090

 

 

 

 

long-term borrowings

64.326

69.899

125.173

Short term borrowings

0.000

29.753

56.358

Total borrowings

64.326

99.652

181.531

Debt/Equity ratio

0.798

0.847

1.025

 

 

YEAR-ON-YEAR GROWTH

 

Year on Year Growth

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

605.940

768.761

1201.737

 

 

26.871

56.321

 

 

NET PROFIT MARGIN

 

Net Profit Margin

31.03.2012

31.03.2013

31.03.2014

 

(Rs. In Million)

(Rs. In Million)

(Rs. In Million)

Sales

605.940

768.761

1201.737

Profit

11.566

21.005

29.903

 

1.91%

2.73%

2.49%

 

 

LOCAL AGENCY FURTHER INFORMATION

 

Sr. No.

Check list by info agents

Available in Report (Yes/No)

1

Year of establishment

Yes

2

Constitution of the entity -Incorporation details

Yes

3

Locality of the entity

Yes

4

Premises details

No

5

Buyer visit details

--

6

Contact numbers

Yes

7

Name of the person contacted

Yes

8

Designation of contact person

Yes

9

Promoter’s background

Yes

10

Date of Birth of Proprietor / Partners / Directors

Yes

11

Pan Card No. of Proprietor / Partners

Yes

12

Voter Id Card No. of Proprietor / Partners

No

13

Type of business

Yes

14

Line of Business

Yes

15

Export/import details (if applicable)

Yes

16

No. of employees

Yes

17

Details of sister concerns

Yes

18

Major suppliers

No

19

Major customers

Yes

20

Banking Details

Yes

21

Banking facility details

Yes

22

Conduct of the banking account

--

23

Financials, if provided

Yes

24

Capital in the business

Yes

25

Last accounts filed at ROC, if applicable

Yes

26

Turnover of firm for last three years

Yes

27

Reasons for variation <> 20%

--

28

Estimation for coming financial year

No

29

Profitability for last four years

Yes

30

Major shareholders, if available

Yes

31

External Agency Rating, if available

No

32

Litigations that the firm/promoter involved in

--

33

Market information

--

34

Payments terms

Yes

35

Negative Reporting by Auditors in the Annual Report

No

 

NOTE: Registered office of the company has been shifted from to 3rd Floor, Narmada Arcade Snehapuri Colony, Nacharam, Hyderabad - 500076, Andhra Pradesh, India the present address w.e.f. 01.02.2014

 

UNSECURED LOAN

(Rs. In Million)

Particulars

As on

31.03.2014

As on

31.03.2013

LONG TERM BORROWING

 

 

Rupee term loans from bank

51.201

45.597

 

 

 

Total

51.201

45.597

 

 

INDEX OF CHARGES:

 

S.No.

Charge ID

Date of Charge Creation/Modification

Charge amount secured

Charge Holder

Address

Service Request Number (SRN)

1

10577123

25/06/2015

145,000,000.00

ICICI BANK LIMITED

LANDMARKRACE COURCE CIRCLE, ALKAPURI, VADODARA - 390015, GUJARAT, INDIA

C57565632

2

10542994

31/12/2014

11,010,552.00

RELIANCE CAPITAL LIMITED

"H" BLOCK 1ST FLOOR, DHIRUBHAI AMBANI KNOWLEDGE CITY,KOPARKHAIRNE, NAVI MUMBAI - 400710, MAHARASHTRA, INDIA

C40416844

3

10461563

25/01/2014 *

160,000,000.00

AXIS BANK LIMITED

1 ST FLOOR,G.PULLAREDDY BUILDING, 6-3-879/B,GREEN 
LANDS,BEGUMPET, HYDERABAD- 500016, TELANGANA, INDIA

B96458484

4

10314834

19/10/2012 *

115,000,000.00

STANDARD CHARTERED BANK

DOOR NO. 8-2-293/82/A/646A, GR FLOOR, ADITYARAM SQUARE, ROAD NO. 36, JUBILEE HILLS,, HYDERABAD- 500003, TELANGANA, INDIA

B60753217

5

10305668

25/01/2014 *

115,000,000.00

STANDARD CHARTERED BANK

DOOR NO.8-2-293/82/A/646A,GR FLR, ADITYARAM SQUARE , ROAD NO. 36, JUBILEE HILLS, HYDERABAD- 500003, TELANGANA, INDIA

C32668162

 

 

 

FIXED ASSETS

·         Factory Land

·         Factory Building

·         Pollution Control Plant

·         Lab Equipment

·         Plant and Machinery

·         Furniture and Fixtures

 

 

CMT REPORT (Corruption, Money Laundering & Terrorism]

 

The Public Notice information has been collected from various sources including but not limited to: The Courts, India Prisons Service, Interpol, etc.

 

1]         INFORMATION ON DESIGNATED PARTY

No exist designating subject or any of its beneficial owners, controlling shareholders or senior officers as terrorist or terrorist organization or whom notice had been received that all financial transactions involving their assets have been blocked or convicted, found guilty or against whom a judgement or order had been entered in a proceedings for violating money-laundering, anti-corruption or bribery or international economic or anti-terrorism sanction laws or whose assets were seized, blocked, frozen or ordered forfeited for violation of money laundering or international anti-terrorism laws.

 

2]         Court Declaration :

No exist to suggest that subject is or was the subject of any formal or informal allegations, prosecutions or other official proceeding for making any prohibited payments or other improper payments to government officials for engaging in prohibited transactions or with designated parties.

 

3]         Asset Declaration :

No records exist to suggest that the property or assets of the subject are derived from criminal conduct or a prohibited transaction.

 

4]         Record on Financial Crime :

            Charges or conviction registered against subject:                                                                       None

 

5]         Records on Violation of Anti-Corruption Laws :

            Charges or investigation registered against subject:                                                        None

 

6]         Records on Int’l Anti-Money Laundering Laws/Standards :

            Charges or investigation registered against subject:                                                        None

 

7]         Criminal Records

No available information exist that suggest that subject or any of its principals have been formally charged or convicted by a competent governmental authority for any financial crime or under any formal investigation by a competent government authority for any violation of anti-corruption laws or international anti-money laundering laws or standard.

 

8]         Affiliation with Government :

No record exists to suggest that any director or indirect owners, controlling shareholders, director, officer or employee of the company is a government official or a family member or close business associate of a Government official.

 

9]         Compensation Package :

Our market survey revealed that the amount of compensation sought by the subject is fair and reasonable and comparable to compensation paid to others for similar services.

 

10]        Press Report :

            No press reports / filings exists on the subject.

 

CORPORATE GOVERNANCE

 

MIRA INFORM as part of its Due Diligence do provide comments on Corporate Governance to identify management and governance. These factors often have been predictive and in some cases have created vulnerabilities to credit deterioration.

 

Our Governance Assessment focuses principally on the interactions between a company’s management, its Board of Directors, Shareholders and other financial stakeholders.

 

 

CONTRAVENTION

 

Subject is not known to have contravened any existing local laws, regulations or policies that prohibit, restrict or otherwise affect the terms and conditions that could be included in the agreement with the subject.

 

 

FOREIGN EXCHANGE RATES

 

Currency
Unit

Indian Rupees

US Dollar

1

Rs.66.08

UK Pound

1

Rs.100.31

Euro

1

Rs.73.81

 

 

INFORMATION DETAILS

 

Information Gathered by :

PPT

 

 

Analysis Done by :

KAR

 

 

Report Prepared by :

RKI

 

SCORE & RATING EXPLANATIONS

 

SCORE FACTORS

 

RANGE

POINTS

HISTORY

1~10

5

PAID-UP CAPITAL

1~10

5

OPERATING SCALE

1~10

5

FINANCIAL CONDITION

 

 

--BUSINESS SCALE

1~10

5

--PROFITABILITY

1~10

5

--LIQUIDITY

1~10

5

--LEVERAGE

1~10

5

--RESERVES

1~10

5

--CREDIT LINES

1~10

5

--MARGINS

-5~5

--

DEMERIT POINTS

 

 

--BANK CHARGES

YES/NO

YES

--LITIGATION

YES/NO

NO

--OTHER ADVERSE INFORMATION

YES/NO

NO

MERIT POINTS

 

 

--SOLE DISTRIBUTORSHIP

YES/NO

NO

--EXPORT ACTIVITIES

YES/NO

NO

--AFFILIATION

YES/NO

YES

--LISTED

YES/NO

NO

--OTHER MERIT FACTORS

YES/NO

YES

DEFAULTER

 

 

--RBI

YES/NO

NO

--EPF

YES/NO

NO

TOTAL

 

45

 

This score serves as a reference to assess SC’s credit risk and to set the amount of credit to be extended. It is calculated from a composite of weighted scores obtained from each of the major sections of this report. The assessed factors and their relative weights (as indicated through %) are as follows:

 

Financial condition (40%)            Ownership background (20%)                  Payment record (10%)

Credit history (10%)                   Market trend (10%)                                Operational size (10%)

 

 

RATING EXPLANATIONS

 

 

RATING

STATUS

 

 

PROPOSED CREDIT LINE

>86

Aaa

Possesses an extremely sound financial base with the strongest capability for timely payment of interest and principal sums

 

Unlimited

71-85

Aa

Possesses adequate working capital. No caution needed for credit transaction. It has above average (strong) capability for payment of interest and principal sums

 

Large

56-70

A

Financial & operational base are regarded healthy. General unfavourable factors will not cause fatal effect. Satisfactory capability for payment of interest and principal sums

 

Fairly Large

41-55

Ba

Overall operation is considered normal. Capable to meet normal commitments.

 

Satisfactory

26-40

B

Capability to overcome financial difficulties seems comparatively below average.

 

Small

11-25

Ca

Adverse factors are apparent. Repayment of interest and principal sums in default or expected to be in default upon maturity

 

Limited with full security

<10

C

Absolute credit risk exists. Caution needed to be exercised

 

 

Credit not recommended

--

NB

                                       New Business

 

--

 

 

PRIVATE & CONFIDENTIAL : This information is provided to you at your request, you having employed MIPL for such purpose. You will use the information as aid only in determining the propriety of giving credit and generally as an aid to your business and for no other purpose. You will hold the information in strict confidence, and shall not reveal it or make it known to the subject persons, firms or corporations or to any other. MIPL does not warrant the correctness of the information as you hold it free of any liability whatsoever. You will be liable to and indemnify MIPL for any loss, damage or expense, occasioned by your breach or non observance of any one, or more of these conditions

This report is issued at your request without any risk and responsibility on the part of MIRA INFORM PRIVATE LIMITED (MIPL) or its officials.